American Public Education Announces Upcoming Conference Participation
CHARLES TOWN, W.V., May 29, 2025 /PRNewswire/ -- American Public Education, Inc. (Nasdaq: APEI), a portfolio of education companies providing online and campus-based postsecondary education and career learning to over 125,000 students through four subsidiary institutions, today announced its upcoming investor conference participation schedule.
William Blair's 45th Annual Growth Stock Conference – June 3-5, 2025 in Chicago, IL. Angela Selden, President and CEO will be present on June 5th at 8:00am CT and host 1x1 meetings. The presentation will be webcast and available at the Company's investor relations website at https://www.apei.com/events-and-presentations/events-calendar/default.aspx
D.A. Davidson 1st Annual Technology + Consumer Conference – June 9-11, 2025 in Nashville, TN. Angela Selden, President and CEO and Rick Sunderland, CFO, will be available for 1x1 meetings with investors.
About American Public Education
American Public Education, Inc. (Nasdaq: APEI), through its institutions American Public University System, Rasmussen University, Hondros College of Nursing, and Graduate School USA, provides education that transforms lives, advances careers, and improves communities.
APUS, which operates through American Military University and American Public University, is the leading educator to active-duty military and veteran students* and serves approximately 88,000 adult learners worldwide via accessible and affordable higher education.
Rasmussen University is a 125-year-old nursing and health sciences-focused institution that serves approximately 14,600 students across its 20 campuses in six states and online. It also has schools of Business, Technology, Design, Early Childhood Education and Justice Studies.
Hondros College of Nursing focuses on educating pre-licensure nursing students at eight campuses (six in Ohio, one in Indiana, and one in Michigan). It is the largest educator of PN (LPN) nurses in the state of Ohio** and serves approximately 3,700 total students.
Graduate School USA is a leading training provider to the federal workforce with an extensive portfolio of government agency customers. It serves the federal workforce through customized contract training (B2G) to federal agencies and through open enrollment (B2C) to government professionals.
Both APUS and Rasmussen University are institutionally accredited by the Higher Learning Commission (HLC), an institutional accreditation agency recognized by the U.S. Department of Education. Hondros is accredited by the Accrediting Bureau of Health Education Schools (ABHES). Graduate School USA is accredited by the Accrediting Council for Continuing Education & Training (ACCET). For additional information, visit www.apei.com.
*Based on FY 2019 Department of Defense tuition assistance data, as reported by Military Times, and Veterans Administration student enrollment data as of 2024.
**Based on information compiled by the National Council of State Boards of Nursing and Ohio Board of Nursing.
Company ContactFrank TutaloDirector, Public RelationsAmerican Public Education, Inc.ftutalo@apei.com 571-358-3042
Investor RelationsBrian M. Prenoveau, CFAMZ North AmericaDirect: 561-489-5315APEI@mzgroup.us
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-public-education-announces-upcoming-conference-participation-302468813.html
SOURCE American Public Education, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Standard Premium Finance Holdings Positioned as Safe Haven Amid Rising Tariff Pressures
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (Standard Premium), a leading specialty finance company, today reaffirmed its position as a stable, growth-oriented domestic investment option amid rising global trade tensions and tariff-related market volatility. The Company's U.S.-focused business model remains shielded from international trade risks, supporting continued growth performance and resilience. 'Standard Premium operations are entirely domestic, highly regulated and unrelated to global supply chains,' says William Koppelmann, CEO, Standard Premium. 'We remain impervious to the kind of market disruptions that tariffs often create across most sectors.' Standard Premium's core business initiatives are rooted in a steady, service-driven model that is focused on achieving measurable growth milestones. With low exposure to international volatility and a track record of profitable growth, the Company continues to offer investors clarity and consistency. 'We believe disciplined, transparent business models like ours offer long-term value and stability with expanded profitability, investments in growth opportunities and increased shareholder value through all market cycles,' Koppelmann adds. The Company also recently announced a $250,000 stock repurchase program, reinforcing confidence in its strategic direction and financial strength. The program, which runs through November 2, 2025, offers flexibility to return capital to shareholders while supporting continued growth. Backed by record profitability in FY 2024 and Q1 2025, Standard Premium remains dedicated to disciplined expansion, accelerating growth, shareholder value creation and leveraging its operational momentum to drive sustainable long-term performance across evolving market conditions. About Standard Premium Finance Holdings, Inc. Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), is a specialty finance company which has financed premiums on over $2 Billion of property and casualty insurance policies since 1991. We currently operate in 38 states and are seeking M&A opportunities of synergistic businesses to leverage economies of scale. Cautionary Statement Regarding Forward-Looking StatementsThis press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21e of the Securities Exchange Act of 1934, as amended with regard to our anticipated future growth and outlook, including the Company's current plans concerning the stock repurchase plan. Our actual results may differ from expectations presented or implied herein and, consequently, you should not rely on these forward-looking statements as predictions of future events. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations or any change in events, conditions or results. Additional information concerning risk factors relating to our business is contained in Item 1A Risk Factors of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 10, 2025 which is available on the SEC's website at or on the Investor Relations section of our website, Media: Nicholas Turchiano CPR Marketing nturchiano@ 201-641-1911x35Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
38 minutes ago
- Associated Press
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 3, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) "[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
Yahoo
43 minutes ago
- Yahoo
5 High Earnings Yield Value Picks Amid Renewed US-China Tensions
Wall Street had a stellar run in May. The S&P 500 climbed 6.2% and the Nasdaq rose 9.6% —marking the best month for both indices since late 2023. Investors cheered as fears around steep tariffs faded when Trump announced a temporary pause on new trade duties on China and the EU. But the celebration might be short-lived. The tariff threat isn't over — it's just on hold. Uncertainty still looms large. Yesterday, China accused the United States of violating their fragile trade truce by tightening controls on AI chip exports and student visas, raising tensions once again. With both economies deeply linked, even a small rift can shake markets. In times like these, when headlines shift quickly and geopolitical risks stay elevated, investors often look for steadier ground. That's where value investing comes in. By focusing on strong companies with solid fundamentals that are trading below their true worth, investors can ride out the volatility and build long-term wealth when the bigger picture looks uncertain. AngloGold Ashanti plc AU, Orchid Island Capital, Inc. ORC, LATAM Airlines Group LTM, Priority Technology Holdings Inc. PRTH and Allianz SE ALIZY are a few value stocks boasting high earnings yield that can generate handsome returns. Earnings yield, expressed as a percentage, is calculated by dividing a company's annual earnings per share (EPS) by its current stock price. It tells you how much return you might get from a stock's earnings for every dollar you invest. When comparing similar companies, a higher earnings yield suggests the stock may be undervalued, while a lower yield could mean it's overpriced. Earnings yield is simply the reciprocal of the P/E ratio, but it can be more helpful in some cases, especially when comparing stocks to safer investments like government bonds. For example, investors often compare a stock's earnings yield to the 10-year U.S. Treasury yield to see how the stock stacks up against a low-risk alternative. If a stock's earnings yield is lower than the Treasury yield, it might not be worth the risk and could be seen as overvalued. But if the stock's yield is higher, it may offer better returns, making it more attractive—especially for value investors looking for good deals. We have set an Earnings Yield greater than 10% as our primary screening criterion but it alone cannot be used for picking stocks that have the potential to generate solid returns. So, we have added the following parameters to the screen: Estimated EPS growth for the next 12 months greater than or equal to the S&P 500: This metric compares the 12-month forward EPS estimate with the 12-month actual EPS. Average Daily Volume (20 Day) greater than or equal to 100,000: High trading volume implies that a stock has adequate liquidity. Current Price greater than or equal to $5. Buy-Rated Stocks: Stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have been known to outperform peers in any type of market environment. You can see the complete list of today's Zacks #1 Rank stocks here. Our Picks Here we highlight five of the 43 stocks that qualified the screening: AngloGold operates as a gold mining company in Africa, the Americas and Australia. The Zacks Consensus Estimate for AU's 2025 and 2026 earnings implies year-over-year growth of 95% and 6.7%, respectively. Estimates for 2025 and 2026 earnings per share have moved up by 83 cents and 55 cents, respectively, over the past 30 days. AngloGold currently sports a Zacks Rank #1 and has a Value Score of A. Orchid Island is a specialty finance company that invests in residential mortgage-backed securities with principal and interest payments guaranteed by the United States. The Zacks Consensus Estimate for ORC's 2025 and 2026 earnings implies year-over-year growth of 394% and 24.5%, respectively. Estimates for 2025 and 2026 earnings per share have moved up by 20 cents and 23 cents, respectively, over the past 60 days. Orchid Island currently sports a Zacks Rank #1 and has a Value Score of B. LATAM Airlines offers passenger and cargo air transportation across the Americas, the Caribbean, Europe and Oceania. The Zacks Consensus Estimate for LTM's 2025 and 2026 earnings implies year-over-year growth of 27.5% and 20%, respectively. Estimates for 2025 and 2026 earnings per share have moved up by 75 cents and 49 cents, respectively, over the past 60 days. LATAM Airlines currently sports a Zacks Rank #1 and has a Value Score of A. Priority Technology operates as a payment technology company in the United States. The Zacks Consensus Estimate for PRTH's 2025 and 2026 earnings implies year-over-year growth of 108% and 34%, respectively. Estimates for 2025 and 2026 earnings per share have moved up by 2 cents and 9 cents, respectively, over the past 30 days. Priority Technology currently sports a Zacks Rank #1 and has a Value Score of A. Allianz is a provider of property-casualty, life, and health insurance, along with asset management products and services. The Zacks Consensus Estimate for ALIZY's 2025 and 2026 earnings implies year-over-year growth of 16.4% and 9%, respectively. Estimates for 2025 and 2026 earnings per share have moved up by 1 cent each over the past seven days. Allianz currently sports a Zacks Rank #1 and has a Value Score of B. You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AngloGold Ashanti PLC (AU) : Free Stock Analysis Report LATAM Airlines Group S.A. (LTM) : Free Stock Analysis Report Orchid Island Capital, Inc. (ORC) : Free Stock Analysis Report Priority Technology Holdings, Inc. (PRTH) : Free Stock Analysis Report Allianz SE (ALIZY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
